Dova Pharmaceuticals: A Different Business Model Could Lead To Success By: TalkMarkets June 28, 2017 at 04:35 AM EDT Dova's model of acquiring, as well as internally developing, product candidates could set the company apart from competitors. Read More >> Related Stocks: Argenx Se ADR Bristol-Myers Squibb Immunomedics Inc Protalex Inc Rigel Pharmaceuticals Shire Plc Ads